GetPortalImpactFactorByIdResp(projectId=1, id=fe8816453, cover=https://img.medsci.cn/images/journal/cover/2021/XId_202109271314324960.jpg, fullname=Blood Advances, abbr=BLOOD ADV, pyear=暂无数据, frequence=S, articleNumbers=2258, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1.5月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2473-9529, greenSci=https://www.greensci.net/search?kw=2473-9529, scijournal=https://www.scijournal.org/impact-factor-of-BLOOD-ADV.shtml, medsciHotlightString=null, medsciHotlightRealtime=7.189, medsciHotlight=4.532, medsciHotlight5year=2.64867, citescore=6.5, hIndex=39, impactFactor=7.5, orgnization=American Society of Hematology, orgnizationUrl=null, country=UNITED STATES OF AMERICA, countryCn=美国, isOa=1, isOaString=是, sciScie=null, bigclassCas=null, smallclassCas=医学 2 区, website=https://ashpublications.org/bloodadvances, websiteHits=1333, guideForAuthor=https://ashpublications.org/bloodadvances/pages/author-guide, guideForAuthorHits=1523, submitWebsite=https://bloodadvances.msubmit.net/, submitWebsiteHits=1267, content=<p><em style="color: #1a1a1a;">Blood Advances</em><span style="color: #1a1a1a;"> is a semimonthly medical journal published by the </span><a style="color: #115284;" href="http://www.hematology.org/" target="_blank" rel="noopener">American Society of Hematology</a><span style="color: #1a1a1a;">. It is the first journal to join the Blood family in 70 years and is a peer-reviewed, online only, open access journal. Under the direction of founding editor-in-chief Robert Negrin, MD, Stanford University Medical Center, Stanford, CA, the inaugural issue debuted on November 29, 2016.</span><br style="color: #1a1a1a;" /><br style="color: #1a1a1a;" /><em style="color: #1a1a1a;">Blood Advances</em><span style="color: #1a1a1a;"> provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. The journal covers all aspects of hematology, including disorders of leukocytes, both benign and malignant, erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology, and hematologic oncology. All articles undergo a rigorous peer-review and are selected on the basis of the originality of the findings, the superior quality of the work described, and the clarity of presentation.</span><br style="color: #1a1a1a;" /><br style="color: #1a1a1a;" /><em style="color: #1a1a1a;">Disclaimer: The ideas and opinions expressed in Blood Advances do not necessarily reflect those of the American Society of Hematology (ASH) or the Editors of Blood Advances. Publication of an advertisement or other product mention in Blood Advances should not be construed as an endorsement of the product or the manufacturer's claims. Readers are encouraged to contact the manufacturer with any questions about the features or limitations of the products mentioned. ASH does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of the material contained in this periodical. The reader is advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each drug to be administered to verify the dosage, the method and duration of administration, or contraindications. It is the responsibility of the treating physician or other health care professional, relying on his or her independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient.</em></p>, totalCites=16941, brief=BLOOD ADV杂志暂不明确行业，暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=BLOOD ADV在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=fe8816453'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=706, tagName=血液学, createdHits=1), ImpactFactorTagDto(id=2615, tagName=血液病, createdHits=1), ImpactFactorTagDto(id=104479, tagName=淋巴肿瘤, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2020, citescore=6.5)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=2.69), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=5.256), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=5.54), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=5.225), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=7.189)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2473-9529[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Blood Advances[ta], article_number=625, article_number_cn=18, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)